Challenging Recycled Dogma with Monitoring of Biologics and JAK Inhibitors
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Scott Elman, MD, to examine whether laboratory monitoring requirements for systemic dermatologic therapies reflect current evidence. With some prescribing recommendations rooted in data from more than a decade ago, the clinicians discuss where routine testing remains warranted, where it may be unnecessary, and how dermatologists can balance patient safety with the burden of excessive monitoring.
Dr Elman begins by examining laboratory monitoring practices for atopic dermatitis therapies, highlighting important…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.